Clinical trial
Renal Mechanistic Effects of Acute and Chronic Empagliflozin in Heart Failure
NCT05553938 is registered in ClinicalTrials.gov with Yale University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Renal Mechanistic Effects of Acute and Chronic Empagliflozin in Heart Failure
- Lead sponsor
- Yale University
- Phase
- Phase 1
- Overall status
- Active, not recruiting
- Start date
- August 4, 2023
- Completion date
- August 14, 2026
- Enrollment
- 60 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.